|
PCMTD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.439780E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.406400E-01 |
| Normal-vs-Stage2 |
8.361000E-01 |
| Normal-vs-Stage3 |
1.844350E-02 |
| Normal-vs-Stage4 |
2.218500E-02 |
| Stage1-vs-Stage2 |
7.161000E-01 |
| Stage1-vs-Stage3 |
4.321800E-02 |
| Stage1-vs-Stage4 |
7.239600E-02 |
| Stage2-vs-Stage3 |
7.748200E-02 |
| Stage2-vs-Stage4 |
7.025600E-02 |
| Stage3-vs-Stage4 |
8.004800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.532100E-02 |
| Normal-vs-AfricanAmerican |
5.894200E-01 |
| Normal-vs-Asian |
7.482000E-01 |
| Caucasian-vs-AfricanAmerican |
6.230000E-01 |
| Caucasian-vs-Asian |
6.588100E-02 |
| AfricanAmerican-vs-Asian |
4.525600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.671400E-01 |
| Normal-vs-Female |
1.425200E-01 |
| Male-vs-Female |
8.292800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.182200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.243800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.976990E-01 |
| Normal-vs-Age(81-100Yrs) |
5.311600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.157600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.080200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.024000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.082800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.840800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.511600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.82419999999306E-05 |
| Classical-VS-Follicular |
8.695800E-01 |
| Classical-VS-Other |
7.352600E-01 |
| Classical-VS-Normal |
5.456200E-01 |
| Tall-VS-Follicular |
7.011200E-04 |
| Tall-VS-Other |
1.254170E-01 |
| Tall-VS-Normal |
1.601270E-04 |
| Follicular-VS-Other |
7.926800E-01 |
| Follicular-VS-Normal |
5.427800E-01 |
| Other-VS-Normal |
5.380400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.747400E-01 |
| Normal-vs-N1 |
6.624100E-02 |
| N0-vs-N1 |
2.836600E-01 |
|
|
